Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 17:9:1543.
doi: 10.3389/fphar.2018.01543. eCollection 2018.

Galenic Preparations of Therapeutic Cannabis sativa Differ in Cannabinoids Concentration: A Quantitative Analysis of Variability and Possible Clinical Implications

Alessandra Bettiol  1   2 , Niccolò Lombardi  1   2 , Giada Crescioli  1   2 , Valentina Maggini  3   4 , Eugenia Gallo  3   4 , Alessandro Mugelli  1   2 , Fabio Firenzuoli  4 , Roberto Baronti  5 , Alfredo Vannacci  1   2
Affiliations

Galenic Preparations of Therapeutic Cannabis sativa Differ in Cannabinoids Concentration: A Quantitative Analysis of Variability and Possible Clinical Implications

Alessandra Bettiol et al. Front Pharmacol. .

Abstract

Introduction: Magistral preparations of therapeutic cannabis are extracted from standardized products imported from Holland or from the Florence Military Pharmaceutical Chemical Works, but extraction protocols differ among galenic laboratories. This study assessed the inter-laboratory variability in concentrations of cannabidiol (CBD), cannabinol (CBN), tetrahydrocannabinol (THC), and tetrahydrocannabinolic acid (THCA) among different magistral oil preparations. Methods: 219 samples of Bediol, Bedrobinol, Bedrolite or FM-2 70 or 100 mg/ml in oil were collected from 3 laboratories. Concentrations of CBD, CBN, THC, and THCA were quantified by high-pressure liquid chromatography; inter-laboratories variability was assessed using the Kruskal-Wallis test. Results: A significant variability in CBD and THC concentrations was found for Bediol 70 mg/ml samples from 2 laboratories [for CBD: median 5.4 (range 4.8-6.6) vs. 6.1 (4.9-7.2) mg/ml, p = 0.033; for THC: 3.6 (3.1-3.9) vs. 4.0 (2.6-5.1) mg/ml, p = 0.020]. As for Bediol 100 mg/ml, a significant variability emerged in THC concentrations among the three considered laboratories [5.7 (-) vs. 4.2 (1.5-4.8) vs. 5.2 (4.2-6.9), p = 0.030]. No significant inter-laboratory variability emerged for Bedrocan and Bedrolite. Concentrations of CBD, CBN, and THC were <LOQ in all Bedrocan samples, and CBN and THCA were <LOQ in all Bedrolite samples. As for FM-2, a significant inter-laboratories variability was found for CBD concentrations. Conclusion: Quantitative variability of cannabinoids in magistral preparations might impact on the efficacy and safety of therapeutic cannabis. A standardized protocol is needed to guarantee a homogeneous product and patients' therapeutic continuity.

Keywords: Bediol®; Bedrocan®; Bedrolite®; FM-2®; cannabis; concentrations variability; galenic preparations.

PubMed Disclaimer

References

    1. Ahmed A. I. A., van den Elsen G. A. H., Colbers A., van der Marck M. A., Burger D. M., Feuth T. B., et al. (2014). Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trial. Eur. Neuropsychopharmacol. 24 1475–1482. 10.1016/j.euroneuro.2014.06.007 - DOI - PubMed
    1. Balash Y., Bar-Lev Schleider L., Korczyn A. D., Shabtai H., Knaani J., Rosenberg A., et al. (2017). Medical cannabis in Parkinson disease: real-life patients’. Exp. Clin. Neuropharmacol. 40 268–272. 10.1097/WNF.0000000000000246 - DOI - PubMed
    1. Boggs D. L., Cortes-Briones J. A., Surti T., Luddy C., Ranganathan M., Cahill J. D., et al. (2018). The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ9-THC) in humans. J. Psychopharmacol. 32 1308–1318. 10.1177/0269881118799953 - DOI - PubMed
    1. Carcieri C., Tomasello C., Simiele M., De Nicolò A., Avataneo V., Canzoneri L., et al. (2018). Cannabinoids concentration variability in cannabis olive oil galenic preparations. J. Pharm. Pharmacol. 70 143–149. 10.1111/jphp.12845 - DOI - PubMed
    1. Citti C., Ciccarella G., Braghiroli D., Parenti C., Vandelli M. A., Cannazza G. (2016). Medicinal cannabis: principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method. J. Pharm. Biomed. Anal. 128 201–209. 10.1016/j.jpba.2016.05.033 - DOI - PubMed